(Q33726237)

28 July 2017

1 reference

title

Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS. (English)

1 reference

cytomegalovirus retinitis

28 July 2017

0 references

1 reference

G L Plosker

1

1 reference

28 July 2017

S Noble

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

58

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

325-345

1 reference

Therapeutic options for resistant cytomegalovirus retinitis

28 July 2017

cites work

1 reference

12 December 2020

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

12 December 2020

Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro

1 reference

12 December 2020

Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov

1 reference

12 December 2020

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

12 December 2020

Susceptibility of human cytomegalovirus to two-drug combinations in vitro

1 reference

12 December 2020

Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).

1 reference

12 December 2020

Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

1 reference

12 December 2020

Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

1 reference

12 December 2020

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

1 reference

12 December 2020

Intravenous cidofovir-induced iritis

1 reference

12 December 2020

Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis

1 reference

12 December 2020

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma

1 reference

12 December 2020

Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

1 reference

12 December 2020

1 reference

12 December 2020

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

1 reference

12 December 2020

Nephrogenic diabetes insipidus in a patient taking cidofovir

1 reference

12 December 2020

Recurrent iritis after intravenous administration of cidofovir

1 reference

12 December 2020

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

Cytomegalovirus disease in AIDS.

1 reference

12 December 2020

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

1 reference

12 December 2020

Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.

1 reference

12 December 2020

Advances in the management of AIDS-related cytomegalovirus retinitis

1 reference

12 December 2020

A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives

1 reference

12 December 2020

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

1 reference

12 December 2020

Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis in patients with AIDS

1 reference

12 December 2020

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease

1 reference

12 December 2020

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

12 December 2020

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

12 December 2020

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

1 reference

12 December 2020

Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts

1 reference

12 December 2020

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients

1 reference

12 December 2020

Cidofovir in the treatment of cytomegaloviral disease.

1 reference

12 December 2020

Management strategies for patients with cytomegalovirus retinitis

1 reference

12 December 2020

Cidofovir: a new therapy for cytomegalovirus retinitis

1 reference

12 December 2020

Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

1 reference

12 December 2020

Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus

1 reference

12 December 2020

A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.

1 reference

12 December 2020

Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study

1 reference

12 December 2020

Summary of the II International Symposium on Cytomegalovirus.

1 reference

12 December 2020

Recent advances. HIV infection-II

1 reference

12 December 2020

Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome

1 reference

12 December 2020

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

1 reference

12 December 2020

Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis

1 reference

12 December 2020

AIDS-related cytomegalovirus retinitis

1 reference

12 December 2020

Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.

1 reference

12 December 2020

Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine

1 reference

12 December 2020

Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect

1 reference

12 December 2020

Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients

1 reference

12 December 2020

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

1 reference

12 December 2020

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Isolation of Foscarnet-Resistant Human Cytomegalovirus Patterns of Resistance and Sensitivity to Other Antiviral Drugs

1 reference

12 December 2020

Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro

1 reference

12 December 2020

Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.

1 reference

12 December 2020

Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro

1 reference

12 December 2020

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

12 December 2020

Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase

1 reference

12 December 2020

Current therapeutic challenges in the treatment of cytomegalovirus retinitis

1 reference

12 December 2020

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

1 reference

12 December 2020

10.2165/00003495-199958020-00015

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1019602490

0 references

1 reference